American Wealth Investing

Explosive Anktiva sales, new cancer data, and fresh approvals are rapidly redefining this immunotherapy story, today, Jan. 16, 2026. ImmunityBio Today’s Change (39.11%) $1.54

It’s hard to beat Vanguard’s S&P 500 ETF. There are plenty of good exchange-traded funds (ETFs) costing less than $1,000 that will likely end

James Brumley, The Motley Fool January 16, 2026 at 12:05 PM Key Points Lingering inflation has forced most consumer goods companies to make unpopular

US stocks were little changed on Friday despite growing uncertainty over the next Fed chair, while strong bank earnings and ongoing geopolitical tensions capped

Chesnot / Getty Images: J. Countess / Getty Images Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content

Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required part of this site couldn’t load. This may be

Investors could get both high dividend yields and high returns with these stocks. Are high dividend yields joined at the hip with low share

WASHINGTON (Gray DC) – A Republican bill in the House to regulate congressional stock trading is moving forward as lawmakers face public pressure to

In brief Bitcoin and Ethereum wavered despite positive momentum earlier this week. One analyst pointed to dashed hopes toward a crypto market structure bill.

HONG KONG (AP) — U.S. businesses are more concerned about China’s slowing economy than trade friction, according to a survey by the American Chamber